First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
| Autor: | D’Angelo, S.P., Lebbé, C., Mortier, L., Brohl, A.S., Fazio, N., Grob, J.-J., Prinzi, N., Hanna, G.J., Hassel, J.C., Kiecker, F., von Heydebreck, A., Güzel, G., Nghiem, P. |
|---|---|
| Zdroj: | In ESMO Open May 2024 9(5) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|